60 DEGREES PHARMACEUTICALS, INC. (SXTP)

SEC fundamentals · as filed in 10-Q FY2026, period ended Jun 30, 2026 · updated Oct 7, 2026

Verified against EDGAR
Total Assets
$4.3M
Stockholders' Equity
$2.6M
Cash & Equivalents
$1.0M
Long-Term Debt
$150,030

as filed in 10-Q FY2026, period ended Jun 30, 2026 · View filings on EDGAR ↗

In its 10-Q for the period ended Jun 30, 2026, 60 DEGREES PHARMACEUTICALS, INC. reported revenue of $207,898, net income of -$2.3M, and total assets of $4.3M. Every figure below is taken directly from 60 DEGREES PHARMACEUTICALS, INC.'s SEC filings: each links to the source document on EDGAR.

Revenue trend

Revenue · FY2022–FY2025 · as reported

$1.0M-$3.5M-$7.9M
FY2022FY2023FY2024FY2025
Revenue$1.0MNet income-$7.4M
FY2022 revenue
$223,208
FY2025 revenue
$1.0M

Revenue and net income by fiscal year

As reported in each year’s annual filing · USD

Fiscal yearRevenueNet income
FY2025$1.0M-$7.4M
FY2024$607,574-$7.9M
FY2023$253,573-$3.8M
FY2022$223,208-$6.2M

Recent SEC filings

Filed by the registrant · newest first · insider forms and holder schedules not included

FormFiledSource
8-KOct 27, 2026on EDGAR ↗
8-KOct 23, 2026on EDGAR ↗
8-KOct 6, 2026on EDGAR ↗
8-KSep 14, 2026on EDGAR ↗
8-KSep 8, 2026on EDGAR ↗
10-QAug 14, 2026on EDGAR ↗
8-KAug 6, 2026on EDGAR ↗
8-KAug 4, 2026on EDGAR ↗
8-KJul 20, 2026on EDGAR ↗
8-KJul 9, 2026on EDGAR ↗

All filings on EDGAR ↗

Balance Sheet

as of Jun 30, 2026 · 10-Q

Total Assets$4.3Msource ↗
Stockholders’ Equity$2.6Msource ↗
Cash & Equivalents$1.0Msource ↗
Long-Term Debt$150,030source ↗

Income Statement

10-Q (quarterly) · period ended Jun 30, 2026

Revenue$207,898source ↗
Net Income-$2.3Msource ↗
Operating Income-$2.3Msource ↗
Gross Profit$56,798source ↗
Cost of Revenue$151,100source ↗
R&D Expense$598,653source ↗

Per Share & Cash Flow

10-Q (quarterly) · period ended Jun 30, 2026

EPS (diluted)$-0.90source ↗
EPS (basic)$-0.90source ↗
Shares Outstanding3.5Msource ↗
Cash from Operations-$2.2Msource ↗
Cash from Financing$0source ↗
Cash from Investing-$85,984source ↗

Insider activity

Form 4 open-market activity, last 180 days

Buys
1
Sells
0
Net shares
+7.3K

Restatement history

Point-in-time

No material restatements detected across 128 annual fact-keys: this company's as-filed numbers have held between filings. Point-in-time and as-of history are available via the API.

Deeper fundamentals

A free API key reaches SXTP’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.

Get a free API key →See plans

Programmatic access

Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.

These fundamentals, as filed
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/fundamentals/SXTP

MCP tool: get_sec_fundamentals ticker=SXTP

The same figures as they were known on any past date
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/fundamentals/SXTP/as-of/YYYY-MM-DD

MCP tool: get_asof_fundamentals ticker=SXTP as_of=YYYY-MM-DD

Fiscal-year trajectory: revenue, margins, free cash flow
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/fundamentals/SXTP/history

MCP tool: get_fundamentals_history ticker=SXTP

Leverage, liquidity, margin and return ratios
curl
curl -H "X-Api-Key: $DISTILL_API_KEY" \
  https://api.distillmarkets.com/api/v1/sec/financial-health/SXTP

MCP tool: get_financial_health ticker=SXTP

Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.